US Site
Out of US
User login
About Exalenz

Exalenz Bioscience Ltd. provides hepatologists and gastroenterologists with advanced systems for diagnosing and managing a wide range of conditions in the fields of liver and GI health. Exalenz` flagship product, BreathID System, is an advanced breath-testing platform that enables the assessment of liver function (hepatic impairment), gastric emptying, and the detection of the Helicobacter pylori bacteria.

News
July 20, 2008
Exalenz received FDA approval to begin Pivotal Phase III trials for diagnosing severity of liver diseases

 


 
Disclaimer: The BreathID System is an exempt Class I device for general purpose use only. In addition, it has the 510(K) and an approved NDA for 13C Urea for use in the detection of H. pylori bacteria. Certain applications are limited by Federal (of United States) Law to Investigational Use only.